Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 17, Issue 16, pp. 5423-5431
PubMed
Published By
Print ISSN
Online ISSN
History
- Received December 30, 2010
- Revision received May 24, 2011
- Accepted June 9, 2011
- Published first July 7, 2011.
Article Versions
- Previous version (July 7, 2011 - 06:52).
- Previous version (August 9, 2011 - 09:32).
- You are viewing the most recent version of this article.
Copyright & Usage
©2011 American Association for Cancer Research.
Author Information
- Kentaro Yamanaka,
- Takahito Nakahara,
- Tomohiro Yamauchi,
- Aya Kita,
- Masahiro Takeuchi,
- Fumiko Kiyonaga,
- Naoki Kaneko, and
- Masao Sasamata
- Corresponding Author:
Kentaro Yamanaka, Institute for Drug Discovery Research, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba-shi, Ibaraki 305-8585, Japan. Phone: 81-29-863-7058; Fax: 81-29-852-5391; E-mail: kentaro.yamanaka{at}jp.astellas.com
August 2011
Volume 17, Issue 16
Volume 17, Issue 16
Antitumor Activity of YM155, a Selective Small-Molecule Survivin Suppressant, Alone and in Combination with Docetaxel in Human Malignant Melanoma Models
Jump to section
Advertisement